Astragaloside IV sensitizes non–small cell lung cancer cells to gefitinib potentially via regulation of SIRT6
Astragaloside IV, the active component of Astragalus membranaceus , exhibits diverse biological roles including the anti-tumor activity. In this study, we evaluated the chemosensitive role of astragaloside IV in non–small cell lung cancer cells. Cell Counting Kit-8 analysis was performed to determin...
Main Authors: | Peng-Chen Dai, De-Ling Liu, Lei Zhang, Jia Ye, Qing Wang, Hong-Wen Zhang, Xiu-Hua Lin, Guo-Xiang Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-04-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317697555 |
Similar Items
-
Neuroprotective Effect of Astragaloside IV on Cerebral Ischemia/Reperfusion Injury Rats Through Sirt1/Mapt Pathway
by: Yi-Hua Shi, et al.
Published: (2021-03-01) -
Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3
by: Cheng-Shi He, et al.
Published: (2016-12-01) -
Astragaloside IV-enhanced anti-hepatocarcinoma immunity of dendritic cells
by: Hongxing Guo, et al.
Published: (2022-05-01) -
Astragaloside IV protects RGC-5 cells against oxidative stress
by: Ming Hao, et al.
Published: (2018-01-01) -
Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer
by: Honggang Wang, et al.
Published: (2017-07-01)